Evaluation of the effect of Modafinil in the treatment of major depressive disorder
Phase 3
- Conditions
- Major depressive disorder.Major depressive disorder, single episode
- Registration Number
- IRCT20180522039784N1
- Lead Sponsor
- Karaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Diagnosis of major depressive disorder
Informed consent
Exclusion Criteria
Diagnosis of bipolar mood disorder, ADHD or any underlying medical disease
Use of any illicit drugs
Use of any medication that interferes modafinil action
Past history of suicide
Past history of receiving ECT
Pregnancy
Daily use of more than 250 mg of caffeine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue severity. Timepoint: Before intervention and 6 weeks after initiation. Method of measurement: Fatigue severity scale.;Mood cahnges. Timepoint: Before intervention and 6 weeks after initiation. Method of measurement: Beck's depression inventory.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: Six weeks after intervention. Method of measurement: Obtaining history.